NA Kernan, G Bartsch, RC Ash, PG Beatty, R … - The New England journal of medicine, 1993 - nejm.highwire.org Results During the first four years of the program, 462 patients with acquired
and congenital lymphohematopoietic disorders or metabolic diseases received
marrow transplants from unrelated donors. The probability of engraftment by ... Cited by 647 - Related articles - BL Direct - All 5 versions
T de Witte, J Hermans, J Vossen, A … - British journal of haematology, 2000 - medwww3.medicine.ufl.edu Theo de Witte,1 Jo Hermans,2 Jaak Vossen,3 Andrea Bacigalupo,4 Giovanna Meloni,5
Niels Jacobsen,6 Tapani Ruutu,7 Per Ljungman,8 Alois Gratwohl,9 Volker Runde,10
Dietger Niederwieser,11 Anja van Biezen,12 Agnes Devergie,13 Jan ... Cited by 138 - Related articles - View as HTML - BL Direct - All 8 versions
- ►hematologylibrary.org - Free from Publisher TJ Nevill, HC Fung, JD Shepherd, DE Horsman … - Blood, 1998 - bloodjournal.hematologylibrary.org Allogeneic bone marrow transplantation (BMT) is the only curative therapy
available for patients with myelodysplastic syndrome (MDS). In an attempt to
identify prognostic factors influencing outcome, we collected data ... Cited by 132 - Related articles - BL Direct - All 5 versions
MJ Thirman, RA Larson - Hematology/oncology clinics of North America, 1996 - Elsevier Therapy-related leukemia is a neoplastic hematopoietic disorder arising in most
cases from a multipotent stem cell and in a few cases from a lineage-committed
progenitor. The terms therapy-related myelodysplastic syndrome (t-MDS) and ... Cited by 128 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org AF List, J Vardiman, JPJ Issa, TM DeWitte - Hematology, 2004 - asheducationbook.hematologylibrary.org The development of new therapeutic strategies for myelodysplastic syndromes
(MDS) has gained new momentum fueled by improved characterization of the
disease's natural history and biology and by the recent US Food and Drug ... Cited by 113 - Related articles - All 6 versions
KB Miller, K Kyungmann, FS Morrison, JN … - Annals of Hematology, 1992 - Springer Summary. One hundred and forty one patients were treated in a combined Eastern
Cooperative Oncology Group and Southwest Oncology Group phase-III study
evaluating low-dose cytarabine (LDAC) versus supportive therapy for the ... Cited by 101 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org T de Witte, S Suciu, G Verhoef, B Labar, E … - Blood, 2001 - bloodjournal.hematologylibrary.org Therefore, we initiated a clinical trial to assess the feasibility and the
efficacy of intensive remission-induction and consolidation chemotherapy,
followed by autologous stem cell transplantation (ASCT) or allogeneic stem ... Cited by 101 - Related articles - BL Direct - All 7 versions
H Hasle - Leukemia & Lymphoma, 1994 - informahealthcare.com Much of the applied terminology of myelodysplastic syndromes (MDS) in childhood
is con- fusing and not mutually exclusive. It is therefore proposed that the FAB
classification of MDS is used in children in order to improve diagnostic ... Cited by 95 - Related articles - BL Direct - All 6 versions
P Fenaux, P Morel, C Rose, JL Lai, JP Jouet, … - British journal of haematology, 1991 - ncbi.nlm.nih.gov We treated 47 adult patients with de novo myelodysplastic syndrome (MDS) by an
anthracycline-AraC regimen. Median age was 54, and M/F 1.3. At diagnosis, 26
patients had refractory anaemia with an excess of blasts in transformation ... Cited by 90 - Related articles - All 2 versions
- ►annals.org JM Rowe, N Ciobanu, J Ascensao, EA … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To define the basic state-of-the-art medical care of the ... Cited by 78 - Related articles - BL Direct - All 3 versions
